ValuEngine Downgrades Nuvectra (NVTR) to Sell
Nuvectra (NASDAQ:NVTR) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a report issued on Friday.
Separately, Piper Jaffray Companies reiterated a “hold” rating and issued a $12.00 price objective on shares of Nuvectra in a research report on Friday, November 3rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. Nuvectra has an average rating of “Hold” and a consensus target price of $12.00.
Shares of Nuvectra (NASDAQ:NVTR) traded up $0.16 during mid-day trading on Friday, reaching $9.06. The company had a trading volume of 23,613 shares, compared to its average volume of 68,153. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.90 and a quick ratio of 2.72. Nuvectra has a 1 year low of $4.90 and a 1 year high of $15.00.
Nuvectra (NASDAQ:NVTR) last announced its quarterly earnings data on Wednesday, November 1st. The company reported ($1.09) EPS for the quarter, topping the Zacks’ consensus estimate of ($1.16) by $0.07. The firm had revenue of $7.60 million during the quarter, compared to analyst estimates of $8.08 million. Nuvectra had a negative return on equity of 68.63% and a negative net margin of 204.19%. The company’s revenue was up 100.0% on a year-over-year basis. During the same period last year, the company earned ($0.92) earnings per share. equities analysts anticipate that Nuvectra will post -4.77 earnings per share for the current fiscal year.
A number of institutional investors and hedge funds have recently modified their holdings of NVTR. Gilder Gagnon Howe & Co. LLC boosted its holdings in Nuvectra by 12.5% during the second quarter. Gilder Gagnon Howe & Co. LLC now owns 953,431 shares of the company’s stock worth $12,662,000 after buying an additional 105,580 shares during the last quarter. EAM Investors LLC bought a new position in Nuvectra during the second quarter worth about $752,000. Hodges Capital Management Inc. boosted its holdings in Nuvectra by 18.6% during the second quarter. Hodges Capital Management Inc. now owns 227,807 shares of the company’s stock worth $3,025,000 after buying an additional 35,706 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Nuvectra by 4.0% during the third quarter. Dimensional Fund Advisors LP now owns 730,117 shares of the company’s stock worth $9,681,000 after buying an additional 28,268 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in Nuvectra by 6.2% during the second quarter. Vanguard Group Inc. now owns 310,794 shares of the company’s stock worth $4,128,000 after buying an additional 18,081 shares during the last quarter. Hedge funds and other institutional investors own 58.89% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was published by Watch List News and is the property of of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/valuengine-downgrades-nuvectra-nvtr-to-sell/1741306.html.
Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.
Receive News & Ratings for Nuvectra Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.